Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Sales of Olainfarm in January Exceed 9 Million Euros | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
By: Nasdaq / GlobeNewswire - 15 Feb 2018 | Back to overview list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Olaine, 2018-02-15 17:03 CET (GLOBE NEWSWIRE) --
Sales numbers of daughter companies of AS Olainfarm that provide significant impact on consolidated results show that sales of Latvijas Aptieka in January reached 2.03 million euros, which represents an increase by 18% compared to January of 2017. Sixty-nine pharmacies were operating during January. Sales of SIA Silvanols during this period were 0.42 million euros, which represents a reduction by 16%. Combined sales of Tonus Elast and its Russian based distributor Elast Medical reached 0.52 million euros. Combined sales of medical companies Diamed and Olainmed reached 0.2 million euros, while sales of Belarus based company NPK Biotest also reached 0.2 million euros.
According to unconsolidated preliminary results, sales of As Olainfarm in January 2018 reached 7.1 million euros, which represents a reduction by 9% compared to the same period of 2017. Biggest sales increase was achieved in Uzbekistan, where sales grew by 237%. Sales to Ukraine grew by 222%, but sales to Kazakhstan grew by 175%. The biggest sales reduction was experienced in The Netherlands, where sales shrunk by 89%. Major sales markets during January were Belarus, Latvia, Russia and Ukraine. In total products of Olainfarm were sold to 27 countries.
Preliminary sales targets of AS Olainfarm for 2018 are being finalized, therefore the percentages of achieved sales targets will be provided beginning with the next monthly sales reports, once budgets for 2018 are approved.
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by: |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright 2018 Nasdaq / GlobeNewswire | Back to overview list |